Cost-benefit analysis of lipid lowering therapy

被引：0
|
作者：
Davie, AP [1 ]
McMurray, JJV [1 ]
机构：
[1] UNIV GLASGOW,GLASGOW,LANARK,SCOTLAND
来源：
EUROPEAN HEART JOURNAL | 1996年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：974 / 975
页数：2
相关论文
共 50 条
  • [1] Cost-benefit analysis of lipid lowering therapy
    Jonsson, B
    Johannesson, M
    [J]. EUROPEAN HEART JOURNAL, 1997, 18 (01) : 165 - 166
  • [2] Cost-benefit analysis of new lipid-lowering agents
    Blaum, Christopher
    Arnold, Natalie
    Waldeyer, Christoph
    [J]. HERZ, 2022, 47 (03) : 236 - 243
  • [3] COST-BENEFIT ANALYSIS OF PSYCHOLOGICAL THERAPY
    Layard, R.
    Clark, D.
    Knapp, M.
    Mayraz, G.
    [J]. NATIONAL INSTITUTE ECONOMIC REVIEW, 2007, 202 (01) : 90 - 98
  • [4] A Cost-Benefit Analysis of Lipid Standardization in the United States
    Hoerger, Thomas J.
    Wittenborn, John S.
    Young, Walter
    [J]. PREVENTING CHRONIC DISEASE, 2011, 8 (06):
  • [5] Cost-benefit analysis
    Miura, Grant
    [J]. NATURE CHEMICAL BIOLOGY, 2018, 14 (10) : 903 - 903
  • [6] COST-BENEFIT ANALYSIS
    BJORNSTAD, P
    [J]. KJEMI, 1975, 35 (10): : 3 - 3
  • [7] A cost-benefit analysis of music therapy in a home hospice
    Romo, Rafael
    Gifford, Lisa
    [J]. NURSING ECONOMICS, 2007, 25 (06): : 353 - 358
  • [8] Lipid lowering therapy in the elderly: Is there a benefit?
    Kalantzi, Kallirroi J.
    Milionis, Haralampos J.
    Mikhailidis, Dimitri P.
    Goudevenos, John A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (30) : 3945 - 3960
  • [9] The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It
    Flyvbjerg, Bent
    Bester, Dirk W.
    [J]. JOURNAL OF BENEFIT-COST ANALYSIS, 2021, 12 (03) : 395 - 419
  • [10] Incommensurability and cost-benefit analysis
    Adler, M
    [J]. UNIVERSITY OF PENNSYLVANIA LAW REVIEW, 1998, 146 (05) : 1371 - 1418
12345